<Click here to download the final program and agenda!>
<Click here to download presentation slides!>
<Click here to register if you are an industry employee or an exhibitor!>
Saturday, February 09, 2013
7:00am - 3:30pm
3315 Peachtree Road, NE
Atlanta, Georgia 30326
Telephone: (404) 946-9115
Valet ($15) or self-park ($8 discounted rate*) your car. Parking will not be validated.
* To receive the discounted self-parking rate, visit the hotel’s parking attendees on the A-Level and pay in person, referencing the Winship Melanoma Conference.
The Winship Melanoma Symposium is 1-day live symposium will specifically address educational gaps pertaining to the multidisciplinary treatment of patients with cutaneous malignancies. Experts in the field will discuss recent advances in the diagnosis and prevention of cutaneous malignancies, including diagnostic challenges in the community setting. Optimal strategies for administration of regional therapy and management of nodal and in-transit disease will also be addressed. In addition, current and emerging therapeutic options for patients with metastatic disease will be discussed, including surgery, targeted therapy, immunotherapy, and adoptive cell therapy. Recent clinical trial data, important ongoing clinical trials, and current treatment recommendations will be highlighted. This engaging program will feature didactic lectures and faculty-led case discussions. These components will provide participants with expert insight on how to apply recent data to their clinical practice and how to better coordinate different disciplines into the multidisciplinary care of cutaneous malignancies, with the goal to improve patient management.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of prIME Oncology and Winship Cancer Institute of Emory University. prIME Oncology is accredited by the ACCME to provide continuing medical education for physicians.
prIME Oncology designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Upon completion of this educational activity, participants should be able to:
Describe recent advances in the diagnosis, screening, and prevention of melanoma
Evaluate optimal approaches for the surgical management of patients with melanoma, including appropriate surgical interventions for patients with primary, regionally metastatic, and widespread metastatic melanoma
Examine recent clinical data regarding best practices for the management of melanoma locoregional recurrences such as in-transit melanoma amenable to regional therapeutic options
Identify optimal treatment strategies for patients with metastatic melanoma, including integration of novel agents and emerging therapeutic approaches
Describe the pathologic features of atypical spitzoid neoplasms and best practices for the management of these tumors
Discuss the importance of a multidisciplinary team in the optimal management of patients with cutaneous malignancies
Questions? Email firstname.lastname@example.org